Let's Connect

News

Artificial Intelligence in Psychiatric Clinical Trials: Opportunities and Limitations

By Industry News 1 min read

​New AI methods investigate clearer depression and schizophrenia subgroups from small, noisy trials, using model abstention to boost interpretability and improve patient stratification.  — From Psychiatric Times articles Read More

Share this post
All News posts
News Industry News 11:33 am Digital Gradebook Engagement Scores May Flag Adolescents at Risk for Substance Use ​Teacher-recorded classroom engagement scores beat GPA at identifying middle schoolers who reported alcohol or cannabis use by eighth grade.  — From Psychiatric Times articles Read More News Industry News 10:33 am FDA Shelves Fast-Track Drug Review Initiative ​The FDA seems to have shelved the fast-track drug review initiative launched during the Trump administration.  — From Psychiatric Times articles Read More News Industry News 10:09 am Oveporexton Now Available: First and Only Orexin Agonist for Narcolepsy Type 1 ​Oveporexton (Orzeyful) is now available in the US by prescription for the treatment of narcolepsy type 1.  — From Psychiatric Times articles Read More

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Follow us

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.